1. 111In-cetuximab as a diagnostic agent by accessible epidermal growth factor (EGF) receptor targeting in human metastatic colorectal carcinoma
   Ying-Hsia Shih et al, 2015, Oncotarget CrossRef
2. New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness
   Isabel Corraliza-Gorjón et al, 2017, Frontiers in Immunology CrossRef
3. EGFR-targeted micelles containing near-infrared dye for enhanced photothermal therapy in colorectal cancer
   Ying-Hsia Shih et al, 2017, Journal of Controlled Release CrossRef
4. Oropharynx und Larynx
   Christine Langer et al, 2022, Medikamentöse Tumortherapie von Kopf-Hals-Tumoren CrossRef
5. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo
   MING QIAN et al, 2014, Oncology Reports CrossRef
6. Antimetastatic Effects of Curcumin in Oral and Gastrointestinal Cancers
   Amirhossein Davoodvandi et al, 2021, Frontiers in Pharmacology CrossRef
7. Integrated single-cell and bulk gene expression and ATAC-seq reveals heterogeneity and early changes in pathways associated with resistance to cetuximab in HNSCC-sensitive cell lines
   Luciane T. Kagohara et al, 2020, British Journal of Cancer CrossRef
8. Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcinoma
   Fei Feng et al, 2017, Cancer Biology & Therapy CrossRef
9. Differences of tumor-recruiting myeloid cells in murine squamous cell carcinoma influence the efficacy of immunotherapy combined with a TLR7 agonist and PD-L1 blockade
   Hidetake Tachinami et al, 2019, Oral Oncology CrossRef
10. Enhanced anticancer effect of cetuximab combined with stabilized silver ion solution in EGFR-positive lung cancer cells
    Aysun Ozkan et al, 2019, Turkish Journal of Biochemistry CrossRef
11. SLC20A1 is a prospective prognostic and therapy response predictive biomarker in head and neck squamous cell carcinoma
    Xiajing Qian et al, 2024, Aging CrossRef
12. Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer
    Alma Campos-Parra et al, 2018, International Journal of Molecular Sciences CrossRef
13. Concurrent chemoradiotherapy using gemcitabine and nedaplatin in recurrent or locally advanced head and neck squamous cell carcinoma
    Rui-Xue Huo et al, 2022, World Journal of Clinical Cases CrossRef
14. Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer
    Loredana Vesci et al, 2016, Oncotarget CrossRef